Global Nuclear Medicine Radioisotopes Sales Market Report 2021

1 Nuclear Medicine Radioisotopes Market Overview

• 1.1 Nuclear Medicine Radioisotopes Product Scope
• 1.2 Nuclear Medicine Radioisotopes Segment by Type
  • 1.2.1 Global Nuclear Medicine Radioisotopes Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Thallium-201 (Tl-201)
  • 1.2.3 Iodine (I-123)
  • 1.2.4 Fluorine-18
  • 1.2.5 Rubidium-82 (Rb-82)
  • 1.2.6 Other
• 1.3 Nuclear Medicine Radioisotopes Segment by Application
  • 1.3.1 Global Nuclear Medicine Radioisotopes Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Tumor
  • 1.3.3 Heart Disease
  • 1.3.4 Lymphoma
  • 1.3.5 Thyroid Gland
  • 1.3.6 Other
• 1.4 Nuclear Medicine Radioisotopes Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Nuclear Medicine Radioisotopes Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Nuclear Medicine Radioisotopes Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Nuclear Medicine Radioisotopes Price Trends (2016-2027)

2 Nuclear Medicine Radioisotopes Estimates and Forecasts by Region

• 2.1 Global Nuclear Medicine Radioisotopes Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Nuclear Medicine Radioisotopes Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2016-2021)
• 2.3 Global Nuclear Medicine Radioisotopes Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Nuclear Medicine Radioisotopes Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Nuclear Medicine Radioisotopes Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Nuclear Medicine Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.2 Europe Nuclear Medicine Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.3 China Nuclear Medicine Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.4 Japan Nuclear Medicine Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Nuclear Medicine Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.6 India Nuclear Medicine Radioisotopes Estimates and Projections (2016-2027)

3 Global Nuclear Medicine Radioisotopes Competition Landscape by Players

• 3.1 Global Top Nuclear Medicine Radioisotopes Players by Sales (2016-2021)
• 3.2 Global Top Nuclear Medicine Radioisotopes Players by Revenue (2016-2021)
• 3.3 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2020)
• 3.4 Global Nuclear Medicine Radioisotopes Average Price by Company (2016-2021)
• 3.5 Manufacturers Nuclear Medicine Radioisotopes Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Nuclear Medicine Radioisotopes Market Size by Type

• 4.1 Global Nuclear Medicine Radioisotopes Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Nuclear Medicine Radioisotopes Price by Type (2016-2021)
• 4.2 Global Nuclear Medicine Radioisotopes Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Nuclear Medicine Radioisotopes Price Forecast by Type (2022-2027)

5 Global Nuclear Medicine Radioisotopes Market Size by Application

• 5.1 Global Nuclear Medicine Radioisotopes Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Nuclear Medicine Radioisotopes Price by Application (2016-2021)
• 5.2 Global Nuclear Medicine Radioisotopes Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Nuclear Medicine Radioisotopes Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Nuclear Medicine Radioisotopes Price Forecast by Application (2022-2027)

6 North America Nuclear Medicine Radioisotopes Market Facts & Figures

• 6.1 North America Nuclear Medicine Radioisotopes Sales by Company
  • 6.1.1 North America Nuclear Medicine Radioisotopes Sales by Company (2016-2021)
  • 6.1.2 North America Nuclear Medicine Radioisotopes Revenue by Company (2016-2021)
• 6.2 North America Nuclear Medicine Radioisotopes Sales Breakdown by Type
  • 6.2.1 North America Nuclear Medicine Radioisotopes Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Nuclear Medicine Radioisotopes Sales Breakdown by Type (2022-2027)
• 6.3 North America Nuclear Medicine Radioisotopes Sales Breakdown by Application
  • 6.3.1 North America Nuclear Medicine Radioisotopes Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Nuclear Medicine Radioisotopes Sales Breakdown by Application (2022-2027)

7 Europe Nuclear Medicine Radioisotopes Market Facts & Figures

• 7.1 Europe Nuclear Medicine Radioisotopes Sales by Company
  • 7.1.1 Europe Nuclear Medicine Radioisotopes Sales by Company (2016-2021)
  • 7.1.2 Europe Nuclear Medicine Radioisotopes Revenue by Company (2016-2021)
• 7.2 Europe Nuclear Medicine Radioisotopes Sales Breakdown by Type
  • 7.2.1 Europe Nuclear Medicine Radioisotopes Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Nuclear Medicine Radioisotopes Sales Breakdown by Type (2022-2027)
• 7.3 Europe Nuclear Medicine Radioisotopes Sales Breakdown by Application
  • 7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Nuclear Medicine Radioisotopes Market Facts & Figures

• 8.1 China Nuclear Medicine Radioisotopes Sales by Company
  • 8.1.1 China Nuclear Medicine Radioisotopes Sales by Company (2016-2021)
  • 8.1.2 China Nuclear Medicine Radioisotopes Revenue by Company (2016-2021)
• 8.2 China Nuclear Medicine Radioisotopes Sales Breakdown by Type
  • 8.2.1 China Nuclear Medicine Radioisotopes Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Nuclear Medicine Radioisotopes Sales Breakdown by Type (2022-2027)
• 8.3 China Nuclear Medicine Radioisotopes Sales Breakdown by Application
  • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Nuclear Medicine Radioisotopes Market Facts & Figures

• 9.1 Japan Nuclear Medicine Radioisotopes Sales by Company
  • 9.1.1 Japan Nuclear Medicine Radioisotopes Sales by Company (2016-2021)
  • 9.1.2 Japan Nuclear Medicine Radioisotopes Revenue by Company (2016-2021)
• 9.2 Japan Nuclear Medicine Radioisotopes Sales Breakdown by Type
  • 9.2.1 Japan Nuclear Medicine Radioisotopes Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Nuclear Medicine Radioisotopes Sales Breakdown by Type (2022-2027)
• 9.3 Japan Nuclear Medicine Radioisotopes Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Nuclear Medicine Radioisotopes Market Facts & Figures

• 10.1 Southeast Asia Nuclear Medicine Radioisotopes Sales by Company
  • 10.1.1 Southeast Asia Nuclear Medicine Radioisotopes Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Nuclear Medicine Radioisotopes Revenue by Company (2016-2021)
• 10.2 Southeast Asia Nuclear Medicine Radioisotopes Sales Breakdown by Type
  • 10.2.1 Southeast Asia Nuclear Medicine Radioisotopes Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Nuclear Medicine Radioisotopes Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Nuclear Medicine Radioisotopes Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Nuclear Medicine Radioisotopes Market Facts & Figures

• 11.1 India Nuclear Medicine Radioisotopes Sales by Company
  • 11.1.1 India Nuclear Medicine Radioisotopes Sales by Company (2016-2021)
  • 11.1.2 India Nuclear Medicine Radioisotopes Revenue by Company (2016-2021)
• 11.2 India Nuclear Medicine Radioisotopes Sales Breakdown by Type
  • 11.2.1 India Nuclear Medicine Radioisotopes Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Nuclear Medicine Radioisotopes Sales Breakdown by Type (2022-2027)
• 11.3 India Nuclear Medicine Radioisotopes Sales Breakdown by Application
  • 11.3.1 India Nuclear Medicine Radioisotopes Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Nuclear Medicine Radioisotopes Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Nuclear Medicine Radioisotopes Business

• 12.1 Agfa-Gevaert Group
  • 12.1.1 Agfa-Gevaert Group Corporation Information
  • 12.1.2 Agfa-Gevaert Group Business Overview
  • 12.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Products Offered
  • 12.1.5 Agfa-Gevaert Group Recent Development
• 12.2 Braco
  • 12.2.1 Braco Corporation Information
  • 12.2.2 Braco Business Overview
  • 12.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Braco Nuclear Medicine Radioisotopes Products Offered
  • 12.2.5 Braco Recent Development
• 12.3 Cardiarc
  • 12.3.1 Cardiarc Corporation Information
  • 12.3.2 Cardiarc Business Overview
  • 12.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Cardiarc Nuclear Medicine Radioisotopes Products Offered
  • 12.3.5 Cardiarc Recent Development
• 12.4 Cardinal Health
  • 12.4.1 Cardinal Health Corporation Information
  • 12.4.2 Cardinal Health Business Overview
  • 12.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Cardinal Health Nuclear Medicine Radioisotopes Products Offered
  • 12.4.5 Cardinal Health Recent Development
• 12.5 CMR Naviscan (Gamma Medica Inc.)
  • 12.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
  • 12.5.2 CMR Naviscan (Gamma Medica Inc.) Business Overview
  • 12.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Products Offered
  • 12.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Development
• 12.6 Curium
  • 12.6.1 Curium Corporation Information
  • 12.6.2 Curium Business Overview
  • 12.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Curium Nuclear Medicine Radioisotopes Products Offered
  • 12.6.5 Curium Recent Development
• 12.7 Digirad
  • 12.7.1 Digirad Corporation Information
  • 12.7.2 Digirad Business Overview
  • 12.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Digirad Nuclear Medicine Radioisotopes Products Offered
  • 12.7.5 Digirad Recent Development
• 12.8 GE Healthcare
  • 12.8.1 GE Healthcare Corporation Information
  • 12.8.2 GE Healthcare Business Overview
  • 12.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 GE Healthcare Nuclear Medicine Radioisotopes Products Offered
  • 12.8.5 GE Healthcare Recent Development
• 12.9 Nordion (Canada)
  • 12.9.1 Nordion (Canada) Corporation Information
  • 12.9.2 Nordion (Canada) Business Overview
  • 12.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Products Offered
  • 12.9.5 Nordion (Canada) Recent Development
• 12.10 NTP Radioisotopes SOC
  • 12.10.1 NTP Radioisotopes SOC Corporation Information
  • 12.10.2 NTP Radioisotopes SOC Business Overview
  • 12.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Products Offered
  • 12.10.5 NTP Radioisotopes SOC Recent Development
• 12.11 Positron
  • 12.11.1 Positron Corporation Information
  • 12.11.2 Positron Business Overview
  • 12.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Positron Nuclear Medicine Radioisotopes Products Offered
  • 12.11.5 Positron Recent Development
• 12.12 Segami
  • 12.12.1 Segami Corporation Information
  • 12.12.2 Segami Business Overview
  • 12.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Segami Nuclear Medicine Radioisotopes Products Offered
  • 12.12.5 Segami Recent Development
• 12.13 Siemens Healthcare
  • 12.13.1 Siemens Healthcare Corporation Information
  • 12.13.2 Siemens Healthcare Business Overview
  • 12.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Products Offered
  • 12.13.5 Siemens Healthcare Recent Development

13 Nuclear Medicine Radioisotopes Manufacturing Cost Analysis

• 13.1 Nuclear Medicine Radioisotopes Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Nuclear Medicine Radioisotopes
• 13.4 Nuclear Medicine Radioisotopes Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Nuclear Medicine Radioisotopes Distributors List
• 14.3 Nuclear Medicine Radioisotopes Customers

15 Market Dynamics

• 15.1 Nuclear Medicine Radioisotopes Market Trends
• 15.2 Nuclear Medicine Radioisotopes Drivers
• 15.3 Nuclear Medicine Radioisotopes Market Challenges
• 15.4 Nuclear Medicine Radioisotopes Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List